CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
Understanding How New Data Integrity Regulations Apply to Your GDP Temperature-controlled Pharmaceuticals
Editorial Archive

Understanding How New Data Integrity Regulations Apply to Your GDP Temperature-controlled Pharmaceuticals

The 2015 UK Data Integrity Guidance states raw data must be “legible and accessible, retained in the format in which it was originally generated, throughout the data...
Continue Reading →
Maintaining Cold Chain Integrity for Pharmaceutical Products
Editorial Archive

Maintaining Cold Chain Integrity for Pharmaceutical Products

Almost 30 per cent of scrapped sales at pharmaceutical companies can be attributed to logistics issues. As most medical and biological products require a temperature...
Continue Reading →
Three ‘Ps’ for Implementing an Effective eCOA Strategy: People, Processes, and Plan
Editorial Archive

Three ‘Ps’ for Implementing an Effective eCOA Strategy: People, Processes, and Plan

Clinical scientists have proven that the collection of clinical outcome assessment data with an electronic device improves patient compliance and delivers higher qua...
Continue Reading →
Pre-fillable Syringes for the Biotechnological Requirements of the Present and Future
Drug Discovery, Development & Delivery V8 I2

Pre-fillable Syringes for the Biotechnological Requirements of the Present and Future

Pre-fillable syringes are both pharmaceutical primary packaging and drug delivery devices. End users, drug administration agencies and the pharmaceutical industry ar...
Continue Reading →
Innovations in the PASS Concept
Drug Discovery, Development & Delivery V8 I2

Innovations in the PASS Concept

Opening the Door to Real-world Data The role of data collected during post-marketing surveillance has recently been widely recognised as being of great value in term...
Continue Reading →
Regulatory Focus on Nanomedicines in US and Europe
Drug Discovery, Development & Delivery V8 I2

Regulatory Focus on Nanomedicines in US and Europe

This article aims to produce an overview of nanotechnology and its drug delivery systems, as well as the regulatory approach for the approval of nanomedicines in reg...
Continue Reading →
Adelaide is the Ideal Life Sciences Location
Editorial Archive

Adelaide is the Ideal Life Sciences Location

Creating an attractive city for health and life sciences companies happens through executing a well-designed strategy backed by a clear vision. Global companies are ...
Continue Reading →
The Great Brain Drain
Editorial Archive

The Great Brain Drain

The life sciences industry is drowning beneath a sea of new regulations and directives. As well as being immensely demanding from a risk management perspective, the ...
Continue Reading →
Incorporating the Patient Perspective: The Critical Role of Human Factors and Usability in Improving Medication Adherence
Editorial Archive

Incorporating the Patient Perspective: The Critical Role of Human Factors and Usability in Improving Medication Adherence

Although we may not always notice it, the products we use in our daily lives continually evolve as manufacturers keep a close eye on consumer behaviour. Typically, t...
Continue Reading →
The NHS Must Invest in Order to Drive Efficencies
Editorial Archive

The NHS Must Invest in Order to Drive Efficencies

The NHS needs to embrace technology for the management of medication and supplies throughout hospitals if it wants to realise the cost savings detailed in the recent...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026